Skip to main content

Open: 2022 Call for Nominations for AACE Officers & Board of Directors — Deadline Jan. 14 Nominate Now

 

Together, We Are AACE

  • ABOUT

  • OUR MISSION

We are a global, inclusive community of endocrine-focused clinical members, affiliates and partners from every walk of professional life. We promote both formal and informal knowledge-sharing through our publications and education- and communication-focused programs. We pride ourselves in offering a uniquely personal experience that gives every member of our community a voice. Learn More

Our mission is elevating the practice of clinical endocrinology to improve global health.Learn More

We are the organization focused on endocrinology, diabetes, and metabolism that is most:

  • Recognized worldwide for its clinical leadership

  • Valued by clinical endocrinologists and other healthcare professionals

  • Trusted by patients

  • Respected by healthcare decision-makers and the public

Learn More

THE LATEST NEWS &
UPDATES

  • The Outlook For Telehealth Post COVID-19 Pandemic

    The Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 [Public Law 116-123] authorized the Secretary of Health and Human Services (HHS) to waive statutory requirements with respect to telehealth services under Medicare for the duration of the COVID-19 Public Health Emergency.

    telehealth
  • AACE 2021 Election Results

    Congratulations to the newly elected Officers and Board members.

    together aace
  • Warning: Recent Uptick in F.A.C.E. Scams

    We have been notified of several fellowship and medical board scams that are targeting physicians by offering a medical certification and/or endocrinology fellowship designation (FACE) from a medical association for a fee.

    scam
  • Community Perspective: FDA OKs Injectable Semaglutide for Chronic Weight Management

    Monica Agarwal MD, MEHP, FACE, provides her perspectives on the recent FDA approval of Semaglutide as an addition to the therapeutic armamentarium of weight management options for people living with obesity. Learn her key takeaways and how the new injectable semaglutide can support adults living with obesity.

    Community Perspective FDA OKs Injectable Semaglutide for Chronic Weight Management
  • Federal Policy Update - July 2021

    In June the U.S. Supreme Court came to the end of its term. Meanwhile, Congress has begun the budget/appropriations process. Learn about the latest federal policy updates and how it can impact the future of health care.

    Federal Policy Update
  • Calendar Year (CY) 2022 Medicare Physician Fee Schedule Proposed Rule

    On July 13, 2021, the Centers for Medicare and Medicaid Services (CMS) posted the proposed rule for the 2022 Physician Fee Schedule (PFS) and other Medicare Part B issues. Learn how the results can bring better accessibility, quality, affordability, empowerment, and innovation.

    2022 Medicare Physician Fee Schedule Proposed Rule
  • 2022 Meetings Update from CEO Paul Markowski

    After over a year of producing virtual events during an uncertain time, we are planning for a potential return to in-person events that brings both excitement and new opportunities. As a valued member of our AACE Community, I would like to be transparent with you and share how we are planning a return to in-person conferences in 2022.

    2022 AACE Meetings Update
  • AACE Position Statement: Coronavirus (COVID-19) Vaccine and the Endocrine Community

    The COVID-19 pandemic entered a new promising phase when the first vaccines for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection became available in late 2020. We at AACE have recommendations for both endocrine patients and care providers.

    covid vaccine
  • Medicare Payment Rules

    On November 2, 2021, the U. S. Department of Health and Human Services Centers for Medicare and Medicaid Services released several final Calendar Year 2022 payment rules. Learn how these rules cover physician fee schedule, hospital outpatient and ambulatory surgical centers, and more.

    Medicare Payment Rules
  • Federal Policy Update - Nov. 2021

    On November 19th, the U.S. House of Representatives passed H.R. 5376, the “Build Back Better Act”. Learn about the new federal policy updates and how it will support the major health care provisions in H.R. 5376.

    Federal Policy Update - Nov. 2021
  • Volunteer Now to Help Update Our Obesity Guidelines

    We're seeking volunteers to update the 2016 Clinical Practice Guidelines for the Medical Care of Patients with Obesity. Volunteer now!

    raising hand to volunteer
  • Federal Policy Update - December 2021 - January 2022

    On December 3, 2021, President Biden signed the "Further Extending Government Funding Act". Public Law 117-70 funds the Federal government through February 18, 2022. It is likely Congress will again consolidate all the bills into one large appropriations bill. The big question is whether Congress can achieve an agreement on full year appropriations or simply pass another continuing resolution.

    Federal Policy Update - Dec. 2021 - Jan. 2022
  • No Surprises Billing Proposed Regulations

    On July 1, 2021, the “No Surprises Act” Interim Final Rule, Part I, was issued. Learn how this announcement is the first in a series of regulations aimed at shielding patients from increased financial hardships stemming from surprise medical bills.

    No Surprises Billing Proposed Regulations
  • Former AADE rebrands as Association of Diabetes Care & Education Specialists

    The former American Association of Diabetes Educators is now the Association of Diabetes Care & Education Specialists (ADCES). The rebranding reflects the association’s shift from referencing the specialty title as “diabetes educator” to the more comprehensive “diabetes care and education specialist.”

  • New Updates to the AACE Diabetes Algorithm

    The AACE diabetes algorithm is a comprehensive management algorithm that covers lifestyle, obesity, prediabetes, lipids, hypertension and glucose management strategies.

  • AACE 2020 Elections: Preliminary Notice of Candidates

    In compliance with the AACE Bylaws, the AACE Nominating Committee is pleased to notify the membership of the selection of the following preliminary slate of candidates for election to Officer positions for a one-year (1) term.

  • President/CEO Update to AACE Members – April 2020

    We continue to think of you during this unprecedented season. While over the last several weeks you have received many helpful pieces of guidance, research, and news updates - today we simply wish to remind you that our priority remains to be you: our members. You are the heart of AACE, and you are our foremost thought that guides anything and everything we do.

  • FDA Requests Withdrawal of Belviq XR (lorcaserin) from the Market

    Due to signals in safety clinical trials showing possible increased risk of cancer, The U.S. Food and Drug Administration (FDA) requested that the manufacturer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market.

COMMUNITY
PERSPECTIVES

I am proud to be an AACE member and to witness the continued growth of this organization.

Dr. Matthew Levine

Read More

One of our great strengths is our diversity: our growing AACE community represents a huge wealth and resource of people of diverse backgrounds.

Dr. Leslie Eldeiry

Read More

I am excited about our AACE and the place for clinical endocrinology in tomorrow’s health care ecosphere.

Dr. Sethu Reddy

Read More